Professor Dore is a renowned infectious diseases physician and clinical epidemiologist. His characterisation of the hepatitis C virus (HCV) epidemic, has informed public health policy and positioned his group as an international leader in HCV epidemiology. His HCV therapeutic research among people who inject drugs has guided clinical management internationally and enhanced access to treatment for this marginalised population.  His high standing is evidenced by extensive conference invitations as well as an outstanding record of peer funding. This is matched by the respect he enjoys in the wider community. He would be a most influential addition to the Fellowship.